Unknown

Dataset Information

0

New genetic players in late-onset Alzheimer's disease: Findings of genome-wide association studies.


ABSTRACT: Late-onset Alzheimer's disease (LOAD) or sporadic AD is the most common form of AD. The precise pathogenetic changes that trigger the development of AD remain largely unknown. Large-scale genome-wide association studies (GWASs) have identified single-nucleotide polymorphisms in multiple genes which are associated with AD; most notably, these are ABCA7, bridging integrator 1 (B1N1), triggering receptor expressed on myeloid cells 2 (TREM2), CD33, clusterin (CLU), complement receptor 1 (CRI), ephrin type-A receptor 1 (EPHA1), membrane-spanning 4-domains, subfamily A (MS4A) and phosphatidylinositol binding clathrin assembly protein (PICALM) genes. The proteins coded by the candidate genes participate in a variety of cellular processes such as oxidative balance, protein metabolism, cholesterol metabolism and synaptic function. This review summarizes the major gene loci affecting LOAD identified by large GWASs. Tentative mechanisms have also been elaborated in various studies by which the proteins coded by these genes may exert a role in AD pathogenesis have also been elaborated. The review suggests that these may together affect LOAD pathogenesis in a complementary fashion.

SUBMITTER: Misra A 

PROVIDER: S-EPMC6206761 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

New genetic players in late-onset Alzheimer's disease: Findings of genome-wide association studies.

Misra Anamika A   Chakrabarti Sankha Shubhra SS   Gambhir Indrajeet Singh IS  

The Indian journal of medical research 20180801 2


Late-onset Alzheimer's disease (LOAD) or sporadic AD is the most common form of AD. The precise pathogenetic changes that trigger the development of AD remain largely unknown. Large-scale genome-wide association studies (GWASs) have identified single-nucleotide polymorphisms in multiple genes which are associated with AD; most notably, these are ABCA7, bridging integrator 1 (B1N1), triggering receptor expressed on myeloid cells 2 (TREM2), CD33, clusterin (CLU), complement receptor 1 (CRI), ephri  ...[more]

Similar Datasets

| S-EPMC4120742 | biostudies-literature
| S-EPMC5554082 | biostudies-literature
| S-EPMC4459905 | biostudies-literature
| S-EPMC2647723 | biostudies-literature
| S-EPMC2751631 | biostudies-literature
| S-EPMC2570675 | biostudies-literature
| S-EPMC6573810 | biostudies-literature
| S-EPMC5659897 | biostudies-literature
| S-EPMC4300162 | biostudies-literature
| S-EPMC3090043 | biostudies-literature